首页 > 最新文献

Traditional Medicine Research最新文献

英文 中文
Underwater electrical explosion of metallic wire and tube: A comparison study 金属线和金属管的水下电气爆炸:对比研究
IF 2.2 4区 医学 Pub Date : 2023-12-18 DOI: 10.1063/5.0180925
Shaojie Zhang, Yongmin Zhang, Yong Lu, Hejie Zhao, Cheng Luo, Haodong Wang, Shuangming Wang, Aici Qiu
With an initial energy storage of approximately 53.5 kJ, experiments on underwater electrical explosions of metallic wire and thin-wall tube were conducted. Two sets of controlled experiments were designed, and the wire and tube for each set were of the same length, cross-sectional area, and material. Load voltage, circuit current, and shock wave pressure were measured and analyzed, and electric power, energy deposition, and energy deposition rate were also calculated and investigated. Experimental results indicated that the underwater electrical tube explosion (UETE) always has higher and earlier local resistance peak, voltage peak, and electric power peak, as well as faster phase transition and ionization process than the underwater electrical wire explosion (UEWE). In addition, the energy deposition rate from the beginning of discharge or the decrease in current to the voltage peak is significantly increased when replacing a wire with a tube. For the shock-wave characteristics, the peak pressure, energy density, and impulse of the shock wave generated by UETE are greater than that generated by UEWE. The peak pressure at ∼33 cm increased from 21.1 to 24.5 MPa in the first set and from 18.1 to 21.7 MPa in the second when a tube was used instead of a wire. These experimental results help us understand the physical process of UETE and provide an alternative methodology for load design in industrial applications.
在初始储能约为 53.5 kJ 的情况下,进行了金属丝和薄壁管的水下电爆炸实验。设计了两组对照实验,每组实验的金属丝和薄壁管的长度、横截面积和材料均相同。对负载电压、电路电流和冲击波压力进行了测量和分析,并计算和研究了电功率、能量沉积和能量沉积率。实验结果表明,与水下电线爆炸(UEWE)相比,水下电管爆炸(UETE)总是具有更高和更早的局部电阻峰值、电压峰值和电功率峰值,以及更快的相变和电离过程。此外,用管子代替电线时,从放电开始或电流减小到电压峰值的能量沉积率也会显著提高。在冲击波特性方面,UETE 产生的冲击波的峰值压力、能量密度和脉冲均大于 UEWE。当使用管子代替金属丝时,第一组在 ∼33 厘米处的峰值压力从 21.1 兆帕增加到 24.5 兆帕,第二组从 18.1 兆帕增加到 21.7 兆帕。这些实验结果有助于我们了解 UETE 的物理过程,并为工业应用中的负载设计提供了一种替代方法。
{"title":"Underwater electrical explosion of metallic wire and tube: A comparison study","authors":"Shaojie Zhang, Yongmin Zhang, Yong Lu, Hejie Zhao, Cheng Luo, Haodong Wang, Shuangming Wang, Aici Qiu","doi":"10.1063/5.0180925","DOIUrl":"https://doi.org/10.1063/5.0180925","url":null,"abstract":"With an initial energy storage of approximately 53.5 kJ, experiments on underwater electrical explosions of metallic wire and thin-wall tube were conducted. Two sets of controlled experiments were designed, and the wire and tube for each set were of the same length, cross-sectional area, and material. Load voltage, circuit current, and shock wave pressure were measured and analyzed, and electric power, energy deposition, and energy deposition rate were also calculated and investigated. Experimental results indicated that the underwater electrical tube explosion (UETE) always has higher and earlier local resistance peak, voltage peak, and electric power peak, as well as faster phase transition and ionization process than the underwater electrical wire explosion (UEWE). In addition, the energy deposition rate from the beginning of discharge or the decrease in current to the voltage peak is significantly increased when replacing a wire with a tube. For the shock-wave characteristics, the peak pressure, energy density, and impulse of the shock wave generated by UETE are greater than that generated by UEWE. The peak pressure at ∼33 cm increased from 21.1 to 24.5 MPa in the first set and from 18.1 to 21.7 MPa in the second when a tube was used instead of a wire. These experimental results help us understand the physical process of UETE and provide an alternative methodology for load design in industrial applications.","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138745344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive Effects of ‘AUM’ Chanting on Mental Health Well-Being 念诵“AUM”对心理健康的积极影响
4区 医学 Pub Date : 2023-05-19 DOI: 10.35702/trad.10015
Anubha Pundir, Akshya Chauhan
Chanting is an ancient practice that has been used for centuries to promote spiritual growth and emotional healing. Om chanting, in particular, is a powerful form of chanting that has gained popularity in recent years due to its reported positive effects on mental health. Mental health is a crucial aspect of well-being and has been linked with overall health and quality of life. The World Health Organization (WHO) defines mental health as a state of well-being where an individual realizes their potentials, copes with the stresses of life, works productively, and contributes to their community. However, mental health issues are on the rise globally, with depression, anxiety, and stress levels increasing among people in different age groups.
念经是一种古老的做法,几个世纪以来一直用于促进精神成长和情感愈合。尤其是吟诵,这是一种强有力的吟诵形式,近年来因其对心理健康的积极影响而受到欢迎。心理健康是幸福的一个重要方面,与整体健康和生活质量密切相关。世界卫生组织(世卫组织)将心理健康定义为个人实现其潜力、应对生活压力、富有成效地工作并为社区作出贡献的一种幸福状态。然而,心理健康问题在全球范围内呈上升趋势,不同年龄组的人的抑郁、焦虑和压力水平都在上升。
{"title":"Positive Effects of ‘AUM’ Chanting on Mental Health Well-Being","authors":"Anubha Pundir, Akshya Chauhan","doi":"10.35702/trad.10015","DOIUrl":"https://doi.org/10.35702/trad.10015","url":null,"abstract":"Chanting is an ancient practice that has been used for centuries to promote spiritual growth and emotional healing. Om chanting, in particular, is a powerful form of chanting that has gained popularity in recent years due to its reported positive effects on mental health. Mental health is a crucial aspect of well-being and has been linked with overall health and quality of life. The World Health Organization (WHO) defines mental health as a state of well-being where an individual realizes their potentials, copes with the stresses of life, works productively, and contributes to their community. However, mental health issues are on the rise globally, with depression, anxiety, and stress levels increasing among people in different age groups.","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135675214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Vitro Establishment, Hydroponic, Salt Tolerance, Antifungal And Phytochemical Investigations In Important Sand Binder Medicinal Plant Ipomoea Pes-Caprae 重要砂胶药用植物甘薯的体外培养、水培、耐盐性、抗真菌和植物化学研究
IF 1.3 4区 医学 Pub Date : 2023-02-02 DOI: 10.35702/trad.10014
S. Khan, Sara Rashed Salem Al Faraji, Mira Said Hamed Almukhaini, Ayaz Mohd, Farrukh Jamal, Samuel S D Premkumar, Priyanka Verma
{"title":"In Vitro Establishment, Hydroponic, Salt Tolerance, Antifungal And Phytochemical Investigations In Important Sand Binder Medicinal Plant Ipomoea Pes-Caprae","authors":"S. Khan, Sara Rashed Salem Al Faraji, Mira Said Hamed Almukhaini, Ayaz Mohd, Farrukh Jamal, Samuel S D Premkumar, Priyanka Verma","doi":"10.35702/trad.10014","DOIUrl":"https://doi.org/10.35702/trad.10014","url":null,"abstract":"","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2023-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85282942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Danlu Tongdu tablets treat lumbar spinal stenosis through reducing reactive oxygen species and apoptosis by regulating CDK2/CDK4/CDKN1A expression 丹芦通度片通过调节CDK2/CDK4/CDKN1A表达,减少活性氧和细胞凋亡,治疗腰椎管狭窄症
4区 医学 Pub Date : 2023-01-18 DOI: 10.53388/tmr20230216003
Xue-yuan Bai, Ayesha T.Tahir, Zheng Yu, Wenbo Cheng, Bo Zhang, Jun Kang
Lumbar spinal stenosis (LSS) is caused by the compression of the nerve root or cauda equina nerve by stenosis of the lumbar spinal canal or intervertebral foramen, and is manifested as chronic low back and leg pain. Danlu Tongdu (DLTD) tablets can relieve chronic pain caused by LSS, but the molecular mechanism remains largely unknown. In this study, the potential molecular mechanism of DLTD tablets in the treatment of LSS was firstly predicted by network pharmacology method. Results showed that DLTD functions in regulating anti-oxidative, apoptosis, and inflammation signaling pathways. Furthermore, the flow cytometry results showed that DLTD tablets efficiently reduced ROS content and inhibited rat neural stem cell apoptosis induced by hydrogen peroxide. DLTD also inhibited the mitochondrial membrane potential damage induced by hydrogen peroxide. Elisa analysis showed that DLTD induced cell cycle related protein, CDK2 and CDK4 and reduced CDKN1A protein expression level. Taken together, our study provided new insights of DLTD in treating LSS through reducing ROS content, decreasing apoptosis by inhibiting CDKN1A and promoting CDK2 and CDK4 expression levels.
腰椎管狭窄症(LSS)是由于腰椎管或椎间孔狭窄压迫神经根或马尾神经而引起的,表现为慢性腰痛和腿痛。丹芦通度片可缓解LSS引起的慢性疼痛,但其分子机制尚不清楚。本研究首次采用网络药理学方法预测了DLTD片治疗LSS的潜在分子机制。结果表明,DLTD具有调节抗氧化、细胞凋亡和炎症信号通路的功能。流式细胞术结果显示,DLTD片能有效降低ROS含量,抑制过氧化氢诱导的大鼠神经干细胞凋亡。DLTD对过氧化氢诱导的线粒体膜潜在损伤也有抑制作用。Elisa分析显示,DLTD诱导细胞周期相关蛋白、CDK2和CDK4表达,降低CDKN1A蛋白表达水平。综上所述,我们的研究为DLTD通过抑制CDKN1A和促进CDK2和CDK4表达水平来降低ROS含量、减少细胞凋亡治疗LSS提供了新的见解。
{"title":"Danlu Tongdu tablets treat lumbar spinal stenosis through reducing reactive oxygen species and apoptosis by regulating CDK2/CDK4/CDKN1A expression","authors":"Xue-yuan Bai, Ayesha T.Tahir, Zheng Yu, Wenbo Cheng, Bo Zhang, Jun Kang","doi":"10.53388/tmr20230216003","DOIUrl":"https://doi.org/10.53388/tmr20230216003","url":null,"abstract":"Lumbar spinal stenosis (LSS) is caused by the compression of the nerve root or cauda equina nerve by stenosis of the lumbar spinal canal or intervertebral foramen, and is manifested as chronic low back and leg pain. Danlu Tongdu (DLTD) tablets can relieve chronic pain caused by LSS, but the molecular mechanism remains largely unknown. In this study, the potential molecular mechanism of DLTD tablets in the treatment of LSS was firstly predicted by network pharmacology method. Results showed that DLTD functions in regulating anti-oxidative, apoptosis, and inflammation signaling pathways. Furthermore, the flow cytometry results showed that DLTD tablets efficiently reduced ROS content and inhibited rat neural stem cell apoptosis induced by hydrogen peroxide. DLTD also inhibited the mitochondrial membrane potential damage induced by hydrogen peroxide. Elisa analysis showed that DLTD induced cell cycle related protein, CDK2 and CDK4 and reduced CDKN1A protein expression level. Taken together, our study provided new insights of DLTD in treating LSS through reducing ROS content, decreasing apoptosis by inhibiting CDKN1A and promoting CDK2 and CDK4 expression levels.","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47095883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of artesunate in diabetes and its complications 青蒿琥酯在糖尿病及其并发症中的研究进展
4区 医学 Pub Date : 2023-01-01 DOI: 10.53388/tmr20220811001
Yuanmei Guo, Lu-lu Chen, Ying Li, Jia-jia Duan, Chuan Liu, Hong-wei Jiang
{"title":"Research progress of artesunate in diabetes and its complications","authors":"Yuanmei Guo, Lu-lu Chen, Ying Li, Jia-jia Duan, Chuan Liu, Hong-wei Jiang","doi":"10.53388/tmr20220811001","DOIUrl":"https://doi.org/10.53388/tmr20220811001","url":null,"abstract":"","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70824898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on prescription medication mode and mechanism of traditional Chinese medicine in the treatment of noncritical COVID-19 based on data mining 基于数据挖掘的非危重型COVID-19中医处方用药模式及机制研究
4区 医学 Pub Date : 2023-01-01 DOI: 10.53388/tmr20221023001
J. Xiong, Jia-Yu Wang, Yi Liu, B. Hao, Yue Zhang, Tiankui Li, Zi-Tong Fu, Q. Qi, Yuliang Zhang, Shishu Sun, Guo-wei Zhang
Background: As of 2023, coronavirus disease 2019 (COVID-19) is still spreading globally. Therefore, we aim to integrate non-critical COVID-19 high-frequency and high-targeting Chinese medicines to provide a reference for clinical prescriptions to improve COVID-19-related symptoms. Materials and methods: The information on non-critical COVID-19 high-frequency Chinese medicines in the diagnosis and treatment of COVID-19 was obtained by the TCM inheritance support platform. Using network pharmacology and molecular docking technology, high-targeting Chinese medicines with good docking activity with COVID-19 receptors angiotensin-converting enzyme-II (ACE2), 3CLpro and tyrosine-protein kinase receptor UFO (AXL) were obtained. A new prescription for non-critical COVID-19 was established by integrating high-frequency and high-targeting Chinese medicines. Rats with acute lung injury induced by lipopolysaccharide were used as the experimental model. The histopathological changes in the lungs of rats in each group were observed by hematoxylin-eosin staining. The lung coefficient of rats was measured. The levels of IL-6, TNF-a, and IL-1ß in serum were detected by enzyme-linked immunosorbent assay. The mRNA and protein levels of ACE2 and AXL in lung tissue were detected by real-time quantitative polymerase chain reaction and western blot. Results: Through data mining, it was found that there were 39 high-frequency traditional Chinese medicines for non-critical COVID-19 in the diagnosis and treatment guidelines. According to network pharmacology and molecular docking, 30 highly targeted traditional Chinese drugs for COVID-19 were found. The new prescriptions for non-critical COVID-19 were comprehensively obtained, including Glycyrrhizae Radix, Ephedra Herba, Amygdalus Communis Vas, Gypsum Fibrosum, Descurainiae Semen, Atractylodes Lancea, Scutellariae Radix, Amomum Tsao-Ko Crevostet, Forsythiae Fructus, Pogostemon cablin, Magnolia Officinalis. Compared with the LPS-induced lung injury model group, the medium dose of the new prescription group had significantly alleviated pathological changes in lung tissue, decreased lung coefficient, decreased contents of IL-6, TNF-a and IL-1ß, and increased mRNA and protein expression of ACE2 and AXL (P < 0.05). Conclusion: Based on data mining, network pharmacology and molecular docking technology, the new prescription for non-critical COVID-19 established by this method has an anti-inflammatory effect on rats with acute lung injury induced by lipopolysaccharide and can provide a reference for clinicians to alleviate the symptoms related to non-critical COVID-19. [ FROM AUTHOR] Copyright of Traditional Medicine Research is the property of TMR Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the a
背景:截至2023年,2019冠状病毒病(COVID-19)仍在全球蔓延。因此,我们的目标是整合非关键的COVID-19高频和高靶向中药,为临床处方提供参考,以改善COVID-19相关症状。材料与方法:通过中医药传承支持平台获取COVID-19非关键高频中药诊治信息。利用网络药理学和分子对接技术,获得与COVID-19受体血管紧张素转换酶- ii (ACE2)、3CLpro和酪氨酸蛋白激酶受体UFO (AXL)对接活性良好的高靶向中药。整合高频、高靶向中药,形成非危重型新方剂。以脂多糖致急性肺损伤大鼠为实验模型。苏木精-伊红染色观察各组大鼠肺组织病理变化。测定大鼠肺系数。采用酶联免疫吸附法检测血清中IL-6、TNF-a、IL-1ß水平。采用实时定量聚合酶链反应和western blot检测肺组织中ACE2和AXL的mRNA和蛋白水平。结果:通过数据挖掘,发现诊疗指南中针对非危重型COVID-19的高频中药有39种。通过网络药理学和分子对接,发现30种靶向性强的新型冠状病毒治疗中药。综合获得非危重型新处方,包括甘草、麻黄、苦杏仁、纤维石膏、景天、苍术、黄芩、草果砂、连翘、广藿香、厚朴等。与lps诱导肺损伤模型组比较,新方中剂量组肺组织病理改变明显减轻,肺系数降低,IL-6、TNF-a、IL-1ß含量降低,ACE2、AXL mRNA及蛋白表达升高(P < 0.05)。结论:基于数据挖掘、网络药理学和分子对接技术,该方法建立的非危重型新冠肺炎方剂对脂多糖急性肺损伤大鼠具有抗炎作用,可为临床医生缓解非危重型新冠肺炎相关症状提供参考。版权归TMR Publishing所有,未经版权所有者明确书面许可,其内容不得复制或通过电子邮件发送到多个网站或发布到listserv。但是,用户可以打印、下载或通过电子邮件发送文章供个人使用。这可以删节。对副本的准确性不作任何保证。用户应参阅原始出版版本的材料的完整。(版权适用于所有人。)
{"title":"Study on prescription medication mode and mechanism of traditional Chinese medicine in the treatment of noncritical COVID-19 based on data mining","authors":"J. Xiong, Jia-Yu Wang, Yi Liu, B. Hao, Yue Zhang, Tiankui Li, Zi-Tong Fu, Q. Qi, Yuliang Zhang, Shishu Sun, Guo-wei Zhang","doi":"10.53388/tmr20221023001","DOIUrl":"https://doi.org/10.53388/tmr20221023001","url":null,"abstract":"Background: As of 2023, coronavirus disease 2019 (COVID-19) is still spreading globally. Therefore, we aim to integrate non-critical COVID-19 high-frequency and high-targeting Chinese medicines to provide a reference for clinical prescriptions to improve COVID-19-related symptoms. Materials and methods: The information on non-critical COVID-19 high-frequency Chinese medicines in the diagnosis and treatment of COVID-19 was obtained by the TCM inheritance support platform. Using network pharmacology and molecular docking technology, high-targeting Chinese medicines with good docking activity with COVID-19 receptors angiotensin-converting enzyme-II (ACE2), 3CLpro and tyrosine-protein kinase receptor UFO (AXL) were obtained. A new prescription for non-critical COVID-19 was established by integrating high-frequency and high-targeting Chinese medicines. Rats with acute lung injury induced by lipopolysaccharide were used as the experimental model. The histopathological changes in the lungs of rats in each group were observed by hematoxylin-eosin staining. The lung coefficient of rats was measured. The levels of IL-6, TNF-a, and IL-1ß in serum were detected by enzyme-linked immunosorbent assay. The mRNA and protein levels of ACE2 and AXL in lung tissue were detected by real-time quantitative polymerase chain reaction and western blot. Results: Through data mining, it was found that there were 39 high-frequency traditional Chinese medicines for non-critical COVID-19 in the diagnosis and treatment guidelines. According to network pharmacology and molecular docking, 30 highly targeted traditional Chinese drugs for COVID-19 were found. The new prescriptions for non-critical COVID-19 were comprehensively obtained, including Glycyrrhizae Radix, Ephedra Herba, Amygdalus Communis Vas, Gypsum Fibrosum, Descurainiae Semen, Atractylodes Lancea, Scutellariae Radix, Amomum Tsao-Ko Crevostet, Forsythiae Fructus, Pogostemon cablin, Magnolia Officinalis. Compared with the LPS-induced lung injury model group, the medium dose of the new prescription group had significantly alleviated pathological changes in lung tissue, decreased lung coefficient, decreased contents of IL-6, TNF-a and IL-1ß, and increased mRNA and protein expression of ACE2 and AXL (P < 0.05). Conclusion: Based on data mining, network pharmacology and molecular docking technology, the new prescription for non-critical COVID-19 established by this method has an anti-inflammatory effect on rats with acute lung injury induced by lipopolysaccharide and can provide a reference for clinicians to alleviate the symptoms related to non-critical COVID-19. [ FROM AUTHOR] Copyright of Traditional Medicine Research is the property of TMR Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the a","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70825088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Theanine combined with cisplatin inhibits the proliferation and metastasis of TNBC cells through Akt signaling pathway 茶氨酸联合顺铂通过Akt信号通路抑制TNBC细胞的增殖和转移
4区 医学 Pub Date : 2023-01-01 DOI: 10.53388/tmr20221025001
Xiao-yu Shi, Xiao-Dan Bao, Yao Li, Cheng-liang Yin
{"title":"Theanine combined with cisplatin inhibits the proliferation and metastasis of TNBC cells through Akt signaling pathway","authors":"Xiao-yu Shi, Xiao-Dan Bao, Yao Li, Cheng-liang Yin","doi":"10.53388/tmr20221025001","DOIUrl":"https://doi.org/10.53388/tmr20221025001","url":null,"abstract":"","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70825151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pharmacological effects and mechanisms of Gastrodia elata and its active ingredients in the treatment of cardiovascular diseases 天麻及其有效成分治疗心血管疾病的药理作用及机制研究
4区 医学 Pub Date : 2023-01-01 DOI: 10.53388/tmr20230425001
Xingyan Chen, Yan He, Ji-Yu Chen
Gastrodia elata , a traditional Chinese medicine belonging to the Orchidaceae family, contains several major components such as gastrodin, polysaccharides of Gastrodia elata , and parishin. The pharmacological studies conducted on Gastrodia elata have revealed a variety of therapeutic properties, including antihypertensive, hypolipidemic, analgesic, and sedative-hypnotic properties. Thus, in this paper, we summarized the pharmacological effects of Gastrodia elata ’s major components, namely gastrodin, polysaccharides of Gastrodia elata , parishin, and different types of Gastrodia elata extracts, on cardiovascular diseases such as atherosclerosis, hypertension, hyperglycemia, myocardial ischemia, myocardial hypoxia, myocarditis, and heart failure. Additionally, we conclude the mechanisms through which these active ingredients exert their therapeutic effects, including antioxidants, anti-inflammatory, and nitric oxide regulation. We provide insights into the therapeutic potential of Gastrodia elata with a detailed review of its pharmacological effects and molecular targets in cardiovascular disease protection and therapy, and can better understand the effect of traditional medicines in cardiovascular disease.
天麻是兰科的一种传统中药,含有天麻素、天麻多糖、天麻素等主要成分。对天麻进行的药理学研究揭示了其多种治疗特性,包括降压、降血脂、镇痛和镇静催眠特性。因此,本文综述了天麻主要成分天麻素、天麻多糖、天麻苷以及不同类型天麻提取物对动脉粥样硬化、高血压、高血糖、心肌缺血、心肌缺氧、心肌炎、心力衰竭等心血管疾病的药理作用。此外,我们还总结了这些活性成分发挥其治疗作用的机制,包括抗氧化、抗炎和一氧化氮调节。我们通过对天麻在心血管疾病保护和治疗中的药理作用和分子靶点的详细综述,深入了解天麻的治疗潜力,更好地了解传统药物在心血管疾病中的作用。
{"title":"Pharmacological effects and mechanisms of Gastrodia elata and its active ingredients in the treatment of cardiovascular diseases","authors":"Xingyan Chen, Yan He, Ji-Yu Chen","doi":"10.53388/tmr20230425001","DOIUrl":"https://doi.org/10.53388/tmr20230425001","url":null,"abstract":"Gastrodia elata , a traditional Chinese medicine belonging to the Orchidaceae family, contains several major components such as gastrodin, polysaccharides of Gastrodia elata , and parishin. The pharmacological studies conducted on Gastrodia elata have revealed a variety of therapeutic properties, including antihypertensive, hypolipidemic, analgesic, and sedative-hypnotic properties. Thus, in this paper, we summarized the pharmacological effects of Gastrodia elata ’s major components, namely gastrodin, polysaccharides of Gastrodia elata , parishin, and different types of Gastrodia elata extracts, on cardiovascular diseases such as atherosclerosis, hypertension, hyperglycemia, myocardial ischemia, myocardial hypoxia, myocarditis, and heart failure. Additionally, we conclude the mechanisms through which these active ingredients exert their therapeutic effects, including antioxidants, anti-inflammatory, and nitric oxide regulation. We provide insights into the therapeutic potential of Gastrodia elata with a detailed review of its pharmacological effects and molecular targets in cardiovascular disease protection and therapy, and can better understand the effect of traditional medicines in cardiovascular disease.","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70825872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effects of oral Shilajit tablets on sexual function and sexual quality of life among reproductive-aged women: a triple-blind randomized clinical trial 口服施拉吉特片对育龄妇女性功能和性生活质量的影响:一项三盲随机临床试验
4区 医学 Pub Date : 2023-01-01 DOI: 10.53388/tmr20230305002
Sadiqa Mosavi, M. Tabarrai, M. Tansaz, H. Salehinia, S. Grylka-Baeschlin, A. Rahmani, S. Shahali
Background: Shilajit is mentioned in the “Kama Sutra” as a potent enhancer of sexual desire. This study aimed to investigate the effects of oral Shilajit tablets on sexual function and sexual quality of life among women of reproductive age. Methods: Forty-eight reproductive-aged women participated in a placebo-controlled triple-blind clinical trial. The intervention group took oral Shilajit tablets (200 mg) twice daily for 60 days and the control group took the placebo. Data collection tools were Sexual Quality of Life-Female and Female Sexual Function Index. Data were collected before the intervention, 30, 60, and 90 days after the start of the study. Results: Forty-three women completed the study. The mean score of total sexual function in the intervention group was significantly higher than before the intervention ( P < 0.001). The mean score of sexual function was 28.93 after 90 days in the intervention group while it was 22.09 in the control group. This finding was observed in most domains of the sexual function index. The mean score of sexual quality of life increased after 60 days of intervention in both groups; however, the difference was not statistically significant ( P = 0.094). Conclusion : The study indicated that Shilajit, as a complementary therapy, may improve sexual function and most of its domains; while there was no effect on improving the quality of sexual life.
背景:shirajit在《爱经》中被提到是一种强有力的性欲增强剂。本研究旨在探讨口服施拉吉特片对育龄妇女性功能及性生活质量的影响。方法:48名育龄妇女参加安慰剂对照三盲临床试验。干预组患者口服施拉吉特片(200 mg),每日2次,连用60 d;对照组患者口服安慰剂。数据收集工具为女性性生活质量指数和女性性功能指数。数据收集于干预前、研究开始后30、60和90天。结果:43名女性完成了这项研究。干预组总性功能平均分显著高于干预前(P < 0.001)。干预组90天后性功能平均分为28.93分,对照组90天后性功能平均分为22.09分。这一发现在性功能指数的大多数领域都可以观察到。干预60天后,两组患者的性生活质量平均得分均有所提高;但差异无统计学意义(P = 0.094)。结论:夏拉吉特作为一种辅助性疗法,具有改善性功能及其大部分领域的作用;而对提高性生活质量没有影响。
{"title":"Effects of oral Shilajit tablets on sexual function and sexual quality of life among reproductive-aged women: a triple-blind randomized clinical trial","authors":"Sadiqa Mosavi, M. Tabarrai, M. Tansaz, H. Salehinia, S. Grylka-Baeschlin, A. Rahmani, S. Shahali","doi":"10.53388/tmr20230305002","DOIUrl":"https://doi.org/10.53388/tmr20230305002","url":null,"abstract":"Background: Shilajit is mentioned in the “Kama Sutra” as a potent enhancer of sexual desire. This study aimed to investigate the effects of oral Shilajit tablets on sexual function and sexual quality of life among women of reproductive age. Methods: Forty-eight reproductive-aged women participated in a placebo-controlled triple-blind clinical trial. The intervention group took oral Shilajit tablets (200 mg) twice daily for 60 days and the control group took the placebo. Data collection tools were Sexual Quality of Life-Female and Female Sexual Function Index. Data were collected before the intervention, 30, 60, and 90 days after the start of the study. Results: Forty-three women completed the study. The mean score of total sexual function in the intervention group was significantly higher than before the intervention ( P < 0.001). The mean score of sexual function was 28.93 after 90 days in the intervention group while it was 22.09 in the control group. This finding was observed in most domains of the sexual function index. The mean score of sexual quality of life increased after 60 days of intervention in both groups; however, the difference was not statistically significant ( P = 0.094). Conclusion : The study indicated that Shilajit, as a complementary therapy, may improve sexual function and most of its domains; while there was no effect on improving the quality of sexual life.","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70826075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Network pharmacology and experimental validation to reveal the anti-hepatitis B virus pharmacological mechanism of Phyllanthus urinaria L. 网络药理学及实验验证揭示余叶草抗乙型肝炎病毒的药理机制。
4区 医学 Pub Date : 2023-01-01 DOI: 10.53388/tmr20230513001
Qian Peng, Qianzeng Fu, Man Xiao, Shenggang Sang, H. Rong
Background: To explore the pharmacological mechanism of the anti-hepatitis B virus of Phyllanthus urinaria L. through network pharmacological analysis and experimental validation. Method: The active ingredient, target of action and target of action related to hepatitis B were clarified by searching the herb group identification, GeneCards and OMIM databases, and the protein interaction relationship was obtained by using the String database, and the protein interaction network map was constructed by using Cytoscape software. We also performed gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis of key targets of the anti-hepatitis B action of Phyllanthus urinaria L. and predicted the core targets and pathways of Phyllanthus urinaria L. anti-hepatitis B. The main targets predicted by network pharmacology were then validated by HepG2.2.15 cell experiments. Results: By searching active ingredient targets and hepatitis B disease targets, a total of 19 active ingredients and 64 related targets of action were retrieved from Phyllanthus urinaria L., and a total of 51 common targets were obtained by mapping the obtained hepatitis B disease targets and drug targets. protein protein interaction network analysis indicated that targets including TNF, JUN, AKT1, IL-10, IL-1B, CAT, HMOX1, NFE2L2, and CASP3 and other targets may be the core targets.gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis showed that the treatment of hepatitis B by Phyllanthus urinaria L. mainly included inflammation and oxidation-related processes, and the signaling pathways mainly included fluid shear stress and atherosclerosis, VEGF, and hepatocellular carcinoma. The results of the in vitro test showed that after the action of different concentrations of the extracts of the Phyllanthus urinaria L. in the safe concentration range on cells HepG2.2.15, HBsAg, HBeAg and hepatitis B virus DNA levels were significantly inhibited, and NFE2L2 and HMOX1 were affecting hepatitis B virus transcription and replication by regulating the oxidative stress response. Conclusion: Using an integrated network pharmacology approach, this study revealed the active components and potential targets of Phyllanthus urinaria L. for the treatment of the hepatitis B virus, providing a theoretical basis for the research and clinical application of Phyllanthus urinaria L..
背景:通过网络药理分析和实验验证,探讨余叶草抗乙型肝炎病毒的药理机制。方法:通过检索中药类群鉴定、GeneCards和OMIM数据库,明确与乙型肝炎相关的有效成分、作用靶点和作用靶点,利用String数据库获得蛋白质相互作用关系,并利用Cytoscape软件构建蛋白质相互作用网络图。我们还对余甘子抗乙肝作用的关键靶点进行了基因本体和京都基因基因组富集分析,预测了余甘子抗乙肝的核心靶点和通路,并通过HepG2.2.15细胞实验对网络药理学预测的主要靶点进行了验证。结果:通过对有效成分靶点和乙肝疾病靶点的检索,共检索到余兰草中19种有效成分和64种相关作用靶点,通过对所获得的乙肝疾病靶点和药物靶点进行制图,共获得51个共同靶点。蛋白-蛋白相互作用网络分析提示TNF、JUN、AKT1、IL-10、IL-1B、CAT、HMOX1、NFE2L2、CASP3等靶点可能是核心靶点。基因本体和京都基因与基因组百科富集分析表明,余叶茶树对乙肝的治疗主要包括炎症和氧化相关过程,其信号通路主要包括流体剪切应力和动脉粥样硬化、VEGF和肝细胞癌。体外实验结果显示,在安全浓度范围内不同浓度的余叶提取物作用于细胞HepG2.2.15后,HBsAg、HBeAg和乙肝病毒DNA水平均被显著抑制,NFE2L2和HMOX1通过调节氧化应激反应影响乙肝病毒转录和复制。结论:本研究采用综合网络药理学方法,揭示了余甘子治疗乙型肝炎病毒的有效成分和潜在靶点,为余甘子的研究和临床应用提供了理论依据。
{"title":"Network pharmacology and experimental validation to reveal the anti-hepatitis B virus pharmacological mechanism of Phyllanthus urinaria L.","authors":"Qian Peng, Qianzeng Fu, Man Xiao, Shenggang Sang, H. Rong","doi":"10.53388/tmr20230513001","DOIUrl":"https://doi.org/10.53388/tmr20230513001","url":null,"abstract":"Background: To explore the pharmacological mechanism of the anti-hepatitis B virus of Phyllanthus urinaria L. through network pharmacological analysis and experimental validation. Method: The active ingredient, target of action and target of action related to hepatitis B were clarified by searching the herb group identification, GeneCards and OMIM databases, and the protein interaction relationship was obtained by using the String database, and the protein interaction network map was constructed by using Cytoscape software. We also performed gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis of key targets of the anti-hepatitis B action of Phyllanthus urinaria L. and predicted the core targets and pathways of Phyllanthus urinaria L. anti-hepatitis B. The main targets predicted by network pharmacology were then validated by HepG2.2.15 cell experiments. Results: By searching active ingredient targets and hepatitis B disease targets, a total of 19 active ingredients and 64 related targets of action were retrieved from Phyllanthus urinaria L., and a total of 51 common targets were obtained by mapping the obtained hepatitis B disease targets and drug targets. protein protein interaction network analysis indicated that targets including TNF, JUN, AKT1, IL-10, IL-1B, CAT, HMOX1, NFE2L2, and CASP3 and other targets may be the core targets.gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis showed that the treatment of hepatitis B by Phyllanthus urinaria L. mainly included inflammation and oxidation-related processes, and the signaling pathways mainly included fluid shear stress and atherosclerosis, VEGF, and hepatocellular carcinoma. The results of the in vitro test showed that after the action of different concentrations of the extracts of the Phyllanthus urinaria L. in the safe concentration range on cells HepG2.2.15, HBsAg, HBeAg and hepatitis B virus DNA levels were significantly inhibited, and NFE2L2 and HMOX1 were affecting hepatitis B virus transcription and replication by regulating the oxidative stress response. Conclusion: Using an integrated network pharmacology approach, this study revealed the active components and potential targets of Phyllanthus urinaria L. for the treatment of the hepatitis B virus, providing a theoretical basis for the research and clinical application of Phyllanthus urinaria L..","PeriodicalId":23192,"journal":{"name":"Traditional Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70826169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Traditional Medicine Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1